Bill Meury got the call early last year after the last company he ran got sold for $3 billion. Billionaire biotech investor Julian C. Baker asked Meury: Would you be interested in running Incyte, a 2, ...
Incyte's valuation still appears attractive if pipeline execution continues and analysts eventually raise long-term ...
Incyte (NasdaqGS: INCY) reported a favorable CHMP opinion for Opzelura in Europe for atopic dermatitis. The company released ...
If you are wondering whether Incyte stock still offers value after a strong run, this article breaks down what the current ...
MSN on MSN
Why Incyte (INCY) stock is up today
What Happened? Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) jumped 3.8% in the morning session after several analyst firms raised their price targets following its acquisition ...
Incyte (INCY) stock dropped 0.78% to $98.22 as Japan approved Minjuvi for relapsed DLBCL treatment, marking the drug's second approval in the country.
Incyte said on Monday it will buy Vega Therapeutics, a wholly owned subsidiary of privately held Star Therapeutics, in a deal worth up to $2 billion, expanding its pipeline for blood disorder ...
CEO William Meury framed Q1 as execution toward a post-Jakafi portfolio, saying, "We're off to a strong start in 2026 with net sales up 20% year-over-year, driven by strong demand across our entire ...
Evan Feinberg founded Genesis Molecular AI seven years ago to take his research at Stanford on AI for drug discovery to the real world. Today the company announced its biggest partnership to date: A ...
(RTTNews) - MorphoSys AG (MOR) and Incyte (INCY) announced the additional real-world evidence results from the RE-MIND2 study comparing tafasitamab (Monjuvi) in combination with lenalidomide against ...
On Saturday, Incyte Corporation (NASDAQ:INCY) revealed results from its pivotal Phase 3 TRuE-PN clinical trial program –TRuE-PN1 and TRuE-PN2 studies – evaluating the safety and efficacy of ...
Incyte INCY is set to give its latest quarterly earnings report on Tuesday, 2025-07-29. Here's what investors need to know before the announcement. Analysts estimate that Incyte will report an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results